181 related articles for article (PubMed ID: 7554993)
21. Advanced glycation end products are associated with beta 2-microglobulin amyloidosis.
Miyazaki S; Niwa T; Morita T; Koda Y; Yuasa Y; Sakai S; Suzuki M; Takahashi S; Hirasawa Y
Am J Nephrol; 1995; 15(6):535-6. PubMed ID: 8546180
[No Abstract] [Full Text] [Related]
22. Beta-2-microglobulin amyloidosis and renal bone disease.
Drüeke TB
Miner Electrolyte Metab; 1991; 17(4):261-72. PubMed ID: 1813789
[TBL] [Abstract][Full Text] [Related]
23. Beta 2-microglobulin-related amyloidosis: where do we stand?
Gejyo F; Arakawa M
Nephrol Dial Transplant; 1995; 10(2):155-7. PubMed ID: 7753446
[No Abstract] [Full Text] [Related]
24. Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloid.
Ehlerding G; Schaeffer J; Drommer W; Miyata T; Koch KM; Floege J
Nephrol Dial Transplant; 1998 Jun; 13(6):1465-75. PubMed ID: 9641177
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous and lingual papules as a sign of beta 2 microglobulin-derived amyloidosis in a long-term hemodialysis patient.
Uenotsuchi T; Imafuku S; Nagata M; Kiryu H; Morita K; Koga T; Furue M
Eur J Dermatol; 2003; 13(4):393-5. PubMed ID: 12948922
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of dialysis-related amyloidosis in diabetic patients. Diabetes Amyloid Study Group.
Lehnert H; Jacob C; Marzoll I; Schmidt-Gayk H; Stein G; Ritz E
Nephrol Dial Transplant; 1996 Oct; 11(10):2004-7. PubMed ID: 8918714
[TBL] [Abstract][Full Text] [Related]
27. The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis.
Miyata T; Hori O; Zhang J; Yan SD; Ferran L; Iida Y; Schmidt AM
J Clin Invest; 1996 Sep; 98(5):1088-94. PubMed ID: 8787669
[TBL] [Abstract][Full Text] [Related]
28. Beta-2-microglobulin and dialysis-related amyloidosis. Recent developments.
Floege J; Wilks MF; Granolleras C; Shaldon S; Koch KM
Contrib Nephrol; 1989; 74():120-6. PubMed ID: 2702128
[No Abstract] [Full Text] [Related]
29. Beta 2-microglobulin, amyloidosis, and dialysis.
Acchiardo S
Int J Artif Organs; 1988 Jul; 11(4):229-31. PubMed ID: 3045017
[No Abstract] [Full Text] [Related]
30. Immunohistochemical localization of beta 2-microglobulin and advanced glycation end products in amyloid-enriched carpal tunnel ligament.
Morita H; Shinzato T; Cai Z; Horiuchi S; Maeda K
Nephron; 1996; 73(1):117-8. PubMed ID: 8742979
[No Abstract] [Full Text] [Related]
31. Amyloid beta 2-microglobulin is modified with N epsilon-(carboxymethyl)lysine in dialysis-related amyloidosis.
Niwa T; Sato M; Katsuzaki T; Tomoo T; Miyazaki T; Tatemichi N; Takei Y; Kondo T
Kidney Int; 1996 Oct; 50(4):1303-9. PubMed ID: 8887292
[TBL] [Abstract][Full Text] [Related]
32. Role of macrophages in beta 2-microglobulin-related dialysis amyloidosis.
Gejyo F; Maruyama H; Teramura T; Kazama J; Ei I; Arakawa M
Contrib Nephrol; 1995; 112():97-104. PubMed ID: 7554998
[No Abstract] [Full Text] [Related]
33. Dialysis arthropathy, amyloidosis and beta-2 microglobulin.
Cameron JS
Pediatr Nephrol; 1987 Apr; 1(2):224-9. PubMed ID: 3153281
[No Abstract] [Full Text] [Related]
34. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
[TBL] [Abstract][Full Text] [Related]
35. Dialysis amyloidosis: beta-2-microglobulin in the context of other amyloidogenic proteins.
Gorevic PD; Munoz P
Blood Purif; 1988; 6(2):132-44. PubMed ID: 3293617
[No Abstract] [Full Text] [Related]
36. Beta-2-microglobulin-related amyloidosis in long-term hemodialysis patients: possible pathogenetic mechanisms.
Drüeke T; Zingraff J
Contrib Nephrol; 1987; 59():99-109. PubMed ID: 3327651
[No Abstract] [Full Text] [Related]
37. Glycation of human beta 2-microglobulin in patients with hemodialysis-associated amyloidosis: identification of the glycated sites.
Miyata T; Inagi R; Wada Y; Ueda Y; Iida Y; Takahashi M; Taniguchi N; Maeda K
Biochemistry; 1994 Oct; 33(40):12215-21. PubMed ID: 7918443
[TBL] [Abstract][Full Text] [Related]
38. Dialysis related amyloidosis.
Bardin T
J Rheumatol; 1987 Aug; 14(4):647-9. PubMed ID: 3312600
[No Abstract] [Full Text] [Related]
39. Clinical aspects of dialysis-related amyloidosis.
Schäffer J; Floege J; Koch KM
Contrib Nephrol; 1995; 112():90-6. PubMed ID: 7554997
[No Abstract] [Full Text] [Related]
40. Amyloidosis and dialysis: pathophysiological aspects.
Drüeke TB; Zingraff J; Noël LH; Bardin T; Kuntz D
Contrib Nephrol; 1988; 62():60-6. PubMed ID: 3282799
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
